The spin-off PhosPrint is one among the 75 SMEs selected for funding in the most recent applications from EIC Accelerator new wave of deep tech start-ups.

PhosPrint is the first Greek company selected by the EIC Accelerator scheme and will translate their research results on the Laser bioprinting device and in vivo applications into pre-clinical and clinics trials.

The 3D laser printer that PhosPrint has developed, allows the successful printing of 100M cells in just 1.6 minutes, targeting enterocystoplasty and bladder cancer. The printing of cells takes place during in vivo surgery and has been effectively tested in pigs. Full adaptation of this method from medical facilities and hospitals after the preclinical trials, prerequires the successful completion of three stages of clinical trials.

PhosPrint’s funding from EIC Accelerator will be used towards the first clinical trial phase.

Read more

 The European Space Agency (ESA) has decided to build the first ground station of the ambitious ARTES ScyLight program next to the Helmos Observatory in Achaia, the National Observatory of Athens’ largest research center.

 FoodPackLab project, funded by the European Commission COSME programme, arises from strategic partnership of 5 clusters linking different value chain activities, industries and countries.

Advanced Technological Process for Producing Tapered Active Fiber Lasers

The development of faster, more efficient automated manufacturing technologies is a crucial requirement to realisation of the 4th industrial revolution, known as Industry 4.0 technologies.

Ultrafast high-power lasers provide the opportunity for industry to perform processes at speeds unimaginable with traditional cutting, welding and drilling techniques. However, the complexity and cost of these high-power systems is a major barrier to their widespread industrial adoption.